Francisco Batel Marques

2.1k citations
91 papers · 1.5k indexed · h-index 22
Topics
Pharmacovigilance and Adverse Drug Reactions (24 papers)Pharmaceutical studies and practices (15 papers)Health Systems, Economic Evaluations, Quality of Life (12 papers)
Journals
SHILAP Revista de lepidopterologíaOncogeneScientific Reports
Partner nations
PortugalSpainBrazil

In The Last Decade

Francisco Batel Marques

86 papers receiving 1.5k citations

Peers

Francisco Batel Marques
Comparison fields: 5 of 127
  • Molecular Biology 321
  • Toxicology 271
  • Oncology 231
  • Endocrinology, Diabetes and Metabolism 219
  • Surgery 212
Replace Rita L. Hui with:
Rita L. Hui United States
Jean‐Paul Fagot France
Carlos Alves Portugal
Diogo Mendes Portugal
W. Marieke Schoonen United Kingdom
Philip Crowe Australia
M P Vessey United Kingdom
Shiro Hinotsu Japan
Karin Jordan Germany
Li Shen China
Francisco Batel Marques relative to Rita L. Hui United States Rita L. Hui's profile →
Citations per field
00.5×5.3×
Rita L. Hui · 1×
Citations per year

Countries citing papers authored by Francisco Batel Marques

Since Specialization
Citations

This map shows the geographic impact of Francisco Batel Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Batel Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Batel Marques more than expected).

Fields of papers citing papers by Francisco Batel Marques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Batel Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Batel Marques. The network helps show where Francisco Batel Marques may publish in the future.

Co-authorship network of co-authors of Francisco Batel Marques

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Batel Marques. A scholar is included among the top collaborators of Francisco Batel Marques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Batel Marques. Francisco Batel Marques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3 0
4 4
5 3
6 72
7 35
8 18
9 44
10 14
11 10
12 16
13 9
14 25
15 25
16 4
17
Quantifying the amount and cost of wasted medicines in Portugal
1
18 40
19 1
20 0

About Francisco Batel Marques

Francisco Batel Marques is a scholar working on Toxicology, Geriatrics and Gerontology and Otorhinolaryngology, having authored 91 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (24 papers), Pharmaceutical studies and practices (15 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). The work is most often cited by research in Toxicology (271 citations), Geriatrics and Gerontology (114 citations) and Otorhinolaryngology (69 citations). Francisco Batel Marques has collaborated with scholars based in Portugal, Spain and Brazil. Frequent co-authors include Carlos Alves, Diogo Mendes, Ana Filipa Macedo, Carlos Ribeiro, Frederico Teixeira, Ilda Patrícia Ribeiro, Isabel M. Carreira, Joana Barbosa Melo, Francisco Caramelo and N. Afonso. Their work appears in journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026